Ting Xiao

CIK: 0002035283

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZBIO

Zenas BioPharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ZBIO
Zenas BioPharma, Inc.
Feb 7, 2025
Purchase(P)
Direct
10K shares at avg. $7.76$78K
ZBIO
Zenas BioPharma, Inc.
Sep 12, 2024
Award(A)
Stock Option (Right to Buy)
Direct
37K shares-

		Type	Shares	Price		Ownership
Feb 7, 2025	ZBIO Zenas BioPharma, Inc.	Purchase(P)	10,000	$7.76	$77,600	Direct
Sep 12, 2024	ZBIO Zenas BioPharma, Inc.	Award(A) Stock Option (Right to Buy)	37,000	-	-	Direct

1-2 of 2 transactions

About Xiao Ting

Xiao Ting (SEC CIK 0002035283) files insider reports with the SEC as Director of Zenas BioPharma, Inc. (ZBIO).

Signal8 holds 4 ownership filings by Xiao Ting (1 Form 3, 3 Form 4), filed between Sep 12, 2024 and Apr 28, 2025. Those filings report 2 transactions, from Sep 12, 2024 to Feb 7, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Xiao Ting's filings is in WALTHAM, MA.

Recent filings by Xiao Ting

Feb 7, 2025: Open-market purchase of ZBIO shares (Form 4, code P).
Sep 12, 2024: Grant or award of ZBIO derivative securities (Form 4, code A).

Other insiders filing for Zenas BioPharma, Inc. (ZBIO)

How to read Form 4 transaction codes